Versant Capital Management’s GeneDx Holdings WGS Stock Holding History

Versant Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.2K	Sell	455 -21	-4%	-$1.19K	﹤0.01%	1693
2026 Q1	$30.6K	Buy	476 +21	+5%	+$1.92K	﹤0.01%	1556
2025 Q4	$59.2K	Hold	455	–	–	0.01%	1001
2025 Q3	$49K	Hold	455	–	–	0.01%	1047
2025 Q2	$42K	Hold	455	–	–	0.01%	1077
2025 Q1	$40.3K	Hold	455	–	–	0.01%	960
2024 Q4	$35K	Hold	455	–	–	0.01%	732
2024 Q3	$19.3K	Hold	455	–	–	﹤0.01%	812
2024 Q2	$11.9K	Hold	455	–	–	﹤0.01%	915
2024 Q1	$4.15K	Hold	455	–	–	﹤0.01%	1099
2023 Q4	$1.25K	Hold	455	–	–	﹤0.01%	1441
2023 Q3	$1.66K	Hold	455	–	–	﹤0.01%	1366
2023 Q2	$2.71K	Hold	455	–	–	﹤0.01%	1263
2023 Q1	$5.47K	Buy	+455	New	+$6.07K	﹤0.01%	911
2021 Q3	–	Sell	-182	Closed	-$84K	–	1616
2021 Q2	$84K	Buy	182 +91	+100%	+$39.1K	0.03%	159
2021 Q1	$45K	Buy	+91	New	+$47.3K	0.02%	304

Other funds holding WGS

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

Slow Capital Greenbrae, California $857M AUM 38.3% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Versant Capital Management's WGS Position: Q2 2026 in Review

Versant Capital Management reduced its GeneDx Holdings (WGS) stake by 4.4% in Q2 2026, selling an estimated $1.19K and leaving 455 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1693.

Versant Capital Management first reported a position in WGS in Q1 2021 and has held it in 16 quarters since. The position peaked at $84K in Q2 2021. 25 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Versant Capital Management held 455 shares of GeneDx Holdings worth $31.2K as of Q2 2026.
Versant Capital Management sold 21 GeneDx Holdings shares in Q2 2026, an estimated $1.19K.
GeneDx Holdings made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1693 holding.
Versant Capital Management first reported a position in GeneDx Holdings in Q1 2021 and has held it in 16 quarters since.
Versant Capital Management's GeneDx Holdings position peaked at $84K in Q2 2021.
25 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.